NovoCure Limited (NVCR)

NMS – Real Time Price. Currency in USD

17.47

-0.19 (-1.08%)

Market open: Aug 12, 2026, 11:57 AM EDT

17.75

+0.09 (0.51%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

655M

605M

509M

538M

Cost of goods sold

-165M

-136M

-128M

-114M

Gross Profit

490M

469M

382M

424M

Operating expenses (excl. COGS)

-642M

-637M

-608M

-512M

Operating Income

-152M

-168M

-226M

-89M

Non-operating income, total

16M

36M

34M

Pretax income

-136M

-131M

-192M

-82M

Equity in earnings

Taxes

23K

-37M

-15M

-11M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-136M

-169M

-207M

-93M

Discontinued operations

Net income

-136M

-169M

-207M

-93M

Dilution adjustment

Preferred dividends

NovoCure Limited (NVCR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NovoCure Limited (NVCR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

NovoCure Limited (NVCR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NovoCure Limited (NVCR)

Income Statement (Annual)

Income Statement (Annual)